Shares of Braiin Ltd (NASDAQ:BRAI – Get Free Report) gapped up prior to trading on Tuesday. The stock had previously closed at $2.50, but opened at $2.96. Braiin shares last traded at $2.75, with a volume of 2,537,131 shares trading hands.
More Braiin News
Here are the key news stories impacting Braiin this week:
- Neutral Sentiment: A broad brain-computer interface market report forecasts an 11.8% compound annual growth rate through 2036, pointing to potential growth in neurotechnology. The article does not identify Braiin or establish that it participates in this market, so the forecast is not a direct catalyst for BRAI. BCI market forecast
- Neutral Sentiment: The other headlines concern general neuroscience and medical research—including Alzheimer’s, Parkinson’s, brain stimulation, and brain health—and do not report developments tied to Braiin.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Braiin in a report on Monday, August 3rd. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Hold” and an average price target of $10.00.
Check Out Our Latest Report on BRAI
Braiin Price Performance
The company’s 50 day moving average is $4.74 and its 200 day moving average is $6.38.
Braiin Company Profile
Braiin Limited is an Australia-based company focused on agriculture, biosecurity and technology. The company develops and provides products, services and data-driven solutions intended to support agricultural productivity, animal health and environmental management.
Braiin’s activities include agricultural and livestock-related solutions, pest and biosecurity management, and technology designed to help customers monitor operations and improve decision-making. Its offerings are aimed primarily at agricultural, rural and environmental applications.
The company serves customers in Australia and may operate internationally through its technology and agricultural businesses.
Featured Articles
- Five stocks we like better than Braiin
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Braiin Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Braiin and related companies with MarketBeat.com's FREE daily email newsletter.
